Immunome (IMNM) Long-Term Deferred Tax (2021 - 2023)

Immunome's Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $130000.0 for Q3 2023.

• Quarterly Long-Term Deferred Tax fell 60.84% year-over-year to $130000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $130000.0 (down 60.84% YoY) and the FY2022 annual result came in at $332000.0, changed 0.0% from the prior year.
• Long-Term Deferred Tax was $130000.0 for Q3 2023 at Immunome, down from $432000.0 in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $432000.0 in Q2 2023 and bottomed at $130000.0 in Q3 2023.
• A 3-year average of $323444.4 and a median of $332000.0 in 2021 frame the typical range for Long-Term Deferred Tax.
• Peak annual rise in Long-Term Deferred Tax reached 30.12% in 2023, while the deepest fall reached 60.84% in 2023.
• Immunome's Long-Term Deferred Tax stood at $332000.0 in 2021, then changed by 0.0% to $332000.0 in 2022, then tumbled by 60.84% to $130000.0 in 2023.
• Business Quant data shows IMNM's Long-Term Deferred Tax at $130000.0 in Q3 2023, $432000.0 in Q2 2023, and $332000.0 in Q1 2023.